Cleared Special

K152330 - Expression MR400 MRI Patient Monitoring System

K152330 is an FDA 510(k) clearance for Expression MR400 MRI Patient Monitoring..., manufactured by Invivo Corporation. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Special 510(k) pathway after a 127-day FDA review.

K152330 · Invivo Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2015
Decision
127d
Days
Class 2
Risk

K152330 is an FDA 510(k) clearance for the Expression MR400 MRI Patient Monitoring System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Invivo Corporation (Orlando, US). The FDA issued a Cleared decision on December 23, 2015 after a review of 127 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Invivo Corporation devices

FDA 510(k) Submission Details - K152330

510(k) Number K152330 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2015
Decision Date December 23, 2015
Days to Decision 127 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 125d · This submission: 127d
Pathway characteristics
Modification to existing cleared device.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Philips Medical Systems
Christine Trefethen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 253
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K152330.
Star 60
K151512 · Skanray Technologies Private Limited · Feb 2016
Masimo Root Vital Signs Monitoring System and Accessories
K151644 · Masimo Corporation · Feb 2016
Dictum Health
K152645 · Dictum Health, Inc. · Feb 2016
ViSi Mobile Monitoring System
K152341 · Sotera Wireless, Inc. · Dec 2015
Checkme Pro Health Monitor
K150869 · Viatom Technology Co., Ltd. · Dec 2015
T3 Software
K151715 · Etiometry, Inc. · Oct 2015